Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SGT-001
SGT-001
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Mon, 12/16/19 - 10:52 am
Axsome Therapeutics
AXS-05
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
major depressive disorder
Intra-Cellular Therapies
lumateperone
schizophrenia
Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity
Stat
Tue, 11/12/19 - 09:52 am
Solid Biosciences
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
SGT-001
Solid Biosciences Surges on DMD Gene Therapy Study Amendments
Yahoo/Zacks.com
Mon, 08/19/19 - 10:54 am
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
Solid Bio is hit by another setback as initial biopsies spotlight a flop for Duchenne MD
Endpoints
Thu, 02/7/19 - 09:37 am
Solid Biosciences
clinical trials
Duchenne Muscular Dystrophy
SGT-001
The 20 Hottest Pipeline Drugs to Watch in 2019
BioSpace
Sun, 01/6/19 - 02:09 pm
VX-659 + tezacaftor + ivacaftor
semaglutide
JCAR017
ARGX-113
aducanumab
elafibranor
NKTR-214
DS-8201
GSK2857916
ozanimod
SGT-001
valoctocogene roxaparvovec
voxelotor
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy
Xconomy
Mon, 06/18/18 - 11:25 am
Duchenne Muscular Dystrophy
Solid Biosciences
Sarepta Therapeutics
SGT-001
Solid Biosciences Provides Update on Clinical Hold of Ph I/II Trial for Duchenne Muscular Dystrophy (DMD)
CP Wire
Wed, 04/18/18 - 09:54 am
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
clinical trials
Solid Biosciences Provides Update on Clinical Hold of Ph I/II Trial for Duchenne Muscular Dystrophy (DMD)
Wed, 04/18/18 - 09:40 am
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy